The economics of the NHS cancer drugs fund

被引：0

作者：

Alan Maynard

Karen Bloor

机构：

[1] University of York,Department of Health Sciences

来源：

Applied Health Economics and Health Policy | 2011年 / 9卷 / 3期

关键词：

Multiple Sclerosis; Political Advantage; Cancer Drug Fund; Maximum Health Gain; Preferential Funding;

D O I：

10.2165/11585750-000000000-00000

中图分类号：

学科分类号：

摘要：

引用

页码：137 / 138

页数：1

共 50 条

[1] The Economics of the NHS Cancer Drugs Fund
Maynard, Alan
Bloor, Karen
APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2011, 9 (03) : 137 - 138
[2] NHS cancer drugs fund
Goodare, Heather
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2019, 112 (02) : 56 - 56
[3] Calling time on the Cancer Drugs Fund? Funding the NHS in the age of austerity
Emmerich, Nathan
BRITISH JOURNAL OF HOSPITAL MEDICINE, 2015, 76 (04) : 186 - 187
[4] NHS England drops 16 medicines from Cancer Drugs Fund
Hawkes, Nigel
BMJ-BRITISH MEDICAL JOURNAL, 2015, 351
[5] Professional experiences of accessing cancer drugs in the NHS: the introduction of the Cancer Drugs Fund, the individual versus the population
Charlotte Chamberlain
Amanda Owen-Smith
William Hollingworth
Jenny Donovan
BMC Health Services Research, 14 (Suppl 2)
[6] Liver cancer drug is rejected for routine NHS use but will remain in Cancer Drugs Fund
Torjesen, Ingrid
BMJ-BRITISH MEDICAL JOURNAL, 2017, 356
[7] Return of the postcode lottery Cancer Drugs Fund is not a fair allocation of NHS resources
Thornton, Sarah
BRITISH MEDICAL JOURNAL, 2011, 342
[8] Drug previously available only through Cancer Drugs Fund is approved for NHS use
Hawkes, Nigel
BMJ-BRITISH MEDICAL JOURNAL, 2016, 354
[9] NHS will not pay for drugs that offer little clinical benefit, says cancer fund boss
Kmietowicz, Zosia
BMJ-BRITISH MEDICAL JOURNAL, 2015, 350
[10] REFORM OF CANCER DRUGS FUND Cancer Drugs Fund: the bigger picture
Longson, Carole M.
Landells, Linda J.
George, Elisabeth
Boysen, Meindert
Dillon, Andrew
BMJ-BRITISH MEDICAL JOURNAL, 2016, 355

← 1 2 3 4 5 →